This report aims to provide a comprehensive presentation of the global market for Chronic Hepatitis B Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Hepatitis B Treatment. This report contains market size and forecasts of Chronic Hepatitis B Treatment in global, including the following market information:
Global Chronic Hepatitis B Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Chronic Hepatitis B Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Interferon Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chronic Hepatitis B Treatment include Novartis, ViiV Healthcare, Bristol-Myers Squibb, Gilead Sciences, Accord Healthcare, Teva Pharmaceuticals, Apotex Corp, CTTQ and Arbutus Biopharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Hepatitis B Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Hepatitis B Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Chronic Hepatitis B Treatment Market Segment Percentages, by Type, 2022 (%)
Interferon
Antiviral Drugs
Global Chronic Hepatitis B Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Chronic Hepatitis B Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Homecare
Clinics
Others
Global Chronic Hepatitis B Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Chronic Hepatitis B Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Hepatitis B Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chronic Hepatitis B Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
ViiV Healthcare
Bristol-Myers Squibb
Gilead Sciences
Accord Healthcare
Teva Pharmaceuticals
Apotex Corp
CTTQ
Arbutus Biopharma
Lupin Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Hepatitis B Treatment, market overview.
Chapter 2: Global Chronic Hepatitis B Treatment market size in revenue.
Chapter 3: Detailed analysis of Chronic Hepatitis B Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Hepatitis B Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Hepatitis B Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Hepatitis B Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Hepatitis B Treatment Overall Market Size
2.1 Global Chronic Hepatitis B Treatment Market Size: 2022 VS 2029
2.2 Global Chronic Hepatitis B Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Hepatitis B Treatment Players in Global Market
3.2 Top Global Chronic Hepatitis B Treatment Companies Ranked by Revenue
3.3 Global Chronic Hepatitis B Treatment Revenue by Companies
3.4 Top 3 and Top 5 Chronic Hepatitis B Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chronic Hepatitis B Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Hepatitis B Treatment Players in Global Market
3.6.1 List of Global Tier 1 Chronic Hepatitis B Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Hepatitis B Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Hepatitis B Treatment Market Size Markets, 2022 & 2029
4.1.2 Interferon
4.1.3 Antiviral Drugs
4.2 By Type - Global Chronic Hepatitis B Treatment Revenue & Forecasts
4.2.1 By Type - Global Chronic Hepatitis B Treatment Revenue, 2018-2023
4.2.2 By Type - Global Chronic Hepatitis B Treatment Revenue, 2024-2029
4.2.3 By Type - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Hepatitis B Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Clinics
5.1.5 Others
5.2 By Application - Global Chronic Hepatitis B Treatment Revenue & Forecasts
5.2.1 By Application - Global Chronic Hepatitis B Treatment Revenue, 2018-2023
5.2.2 By Application - Global Chronic Hepatitis B Treatment Revenue, 2024-2029
5.2.3 By Application - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Chronic Hepatitis B Treatment Market Size, 2022 & 2029
6.2 By Region - Global Chronic Hepatitis B Treatment Revenue & Forecasts
6.2.1 By Region - Global Chronic Hepatitis B Treatment Revenue, 2018-2023
6.2.2 By Region - Global Chronic Hepatitis B Treatment Revenue, 2024-2029
6.2.3 By Region - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Chronic Hepatitis B Treatment Revenue, 2018-2029
6.3.2 US Chronic Hepatitis B Treatment Market Size, 2018-2029
6.3.3 Canada Chronic Hepatitis B Treatment Market Size, 2018-2029
6.3.4 Mexico Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Chronic Hepatitis B Treatment Revenue, 2018-2029
6.4.2 Germany Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.3 France Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.4 U.K. Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.5 Italy Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.6 Russia Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Chronic Hepatitis B Treatment Market Size, 2018-2029
6.4.8 Benelux Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Chronic Hepatitis B Treatment Revenue, 2018-2029
6.5.2 China Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.3 Japan Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.4 South Korea Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Chronic Hepatitis B Treatment Market Size, 2018-2029
6.5.6 India Chronic Hepatitis B Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Chronic Hepatitis B Treatment Revenue, 2018-2029
6.6.2 Brazil Chronic Hepatitis B Treatment Market Size, 2018-2029
6.6.3 Argentina Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Hepatitis B Treatment Revenue, 2018-2029
6.7.2 Turkey Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7.3 Israel Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Chronic Hepatitis B Treatment Market Size, 2018-2029
6.7.5 UAE Chronic Hepatitis B Treatment Market Size, 2018-2029
7 Chronic Hepatitis B Treatment Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Chronic Hepatitis B Treatment Major Product Offerings
7.1.4 Novartis Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 ViiV Healthcare
7.2.1 ViiV Healthcare Company Summary
7.2.2 ViiV Healthcare Business Overview
7.2.3 ViiV Healthcare Chronic Hepatitis B Treatment Major Product Offerings
7.2.4 ViiV Healthcare Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.2.5 ViiV Healthcare Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Chronic Hepatitis B Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Gilead Sciences
7.4.1 Gilead Sciences Company Summary
7.4.2 Gilead Sciences Business Overview
7.4.3 Gilead Sciences Chronic Hepatitis B Treatment Major Product Offerings
7.4.4 Gilead Sciences Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.4.5 Gilead Sciences Key News & Latest Developments
7.5 Accord Healthcare
7.5.1 Accord Healthcare Company Summary
7.5.2 Accord Healthcare Business Overview
7.5.3 Accord Healthcare Chronic Hepatitis B Treatment Major Product Offerings
7.5.4 Accord Healthcare Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.5.5 Accord Healthcare Key News & Latest Developments
7.6 Teva Pharmaceuticals
7.6.1 Teva Pharmaceuticals Company Summary
7.6.2 Teva Pharmaceuticals Business Overview
7.6.3 Teva Pharmaceuticals Chronic Hepatitis B Treatment Major Product Offerings
7.6.4 Teva Pharmaceuticals Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.6.5 Teva Pharmaceuticals Key News & Latest Developments
7.7 Apotex Corp
7.7.1 Apotex Corp Company Summary
7.7.2 Apotex Corp Business Overview
7.7.3 Apotex Corp Chronic Hepatitis B Treatment Major Product Offerings
7.7.4 Apotex Corp Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.7.5 Apotex Corp Key News & Latest Developments
7.8 CTTQ
7.8.1 CTTQ Company Summary
7.8.2 CTTQ Business Overview
7.8.3 CTTQ Chronic Hepatitis B Treatment Major Product Offerings
7.8.4 CTTQ Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.8.5 CTTQ Key News & Latest Developments
7.9 Arbutus Biopharma
7.9.1 Arbutus Biopharma Company Summary
7.9.2 Arbutus Biopharma Business Overview
7.9.3 Arbutus Biopharma Chronic Hepatitis B Treatment Major Product Offerings
7.9.4 Arbutus Biopharma Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.9.5 Arbutus Biopharma Key News & Latest Developments
7.10 Lupin Pharmaceuticals
7.10.1 Lupin Pharmaceuticals Company Summary
7.10.2 Lupin Pharmaceuticals Business Overview
7.10.3 Lupin Pharmaceuticals Chronic Hepatitis B Treatment Major Product Offerings
7.10.4 Lupin Pharmaceuticals Chronic Hepatitis B Treatment Revenue in Global Market (2018-2023)
7.10.5 Lupin Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chronic Hepatitis B Treatment Market Opportunities & Trends in Global Market
Table 2. Chronic Hepatitis B Treatment Market Drivers in Global Market
Table 3. Chronic Hepatitis B Treatment Market Restraints in Global Market
Table 4. Key Players of Chronic Hepatitis B Treatment in Global Market
Table 5. Top Chronic Hepatitis B Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chronic Hepatitis B Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chronic Hepatitis B Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chronic Hepatitis B Treatment Product Type
Table 9. List of Global Tier 1 Chronic Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chronic Hepatitis B Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Chronic Hepatitis B Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chronic Hepatitis B Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Chronic Hepatitis B Treatment Product Offerings
Table 32. Novartis Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. ViiV Healthcare Company Summary
Table 35. ViiV Healthcare Chronic Hepatitis B Treatment Product Offerings
Table 36. ViiV Healthcare Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. ViiV Healthcare Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Chronic Hepatitis B Treatment Product Offerings
Table 40. Bristol-Myers Squibb Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Gilead Sciences Company Summary
Table 43. Gilead Sciences Chronic Hepatitis B Treatment Product Offerings
Table 44. Gilead Sciences Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Gilead Sciences Key News & Latest Developments
Table 46. Accord Healthcare Company Summary
Table 47. Accord Healthcare Chronic Hepatitis B Treatment Product Offerings
Table 48. Accord Healthcare Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Accord Healthcare Key News & Latest Developments
Table 50. Teva Pharmaceuticals Company Summary
Table 51. Teva Pharmaceuticals Chronic Hepatitis B Treatment Product Offerings
Table 52. Teva Pharmaceuticals Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Pharmaceuticals Key News & Latest Developments
Table 54. Apotex Corp Company Summary
Table 55. Apotex Corp Chronic Hepatitis B Treatment Product Offerings
Table 56. Apotex Corp Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Apotex Corp Key News & Latest Developments
Table 58. CTTQ Company Summary
Table 59. CTTQ Chronic Hepatitis B Treatment Product Offerings
Table 60. CTTQ Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. CTTQ Key News & Latest Developments
Table 62. Arbutus Biopharma Company Summary
Table 63. Arbutus Biopharma Chronic Hepatitis B Treatment Product Offerings
Table 64. Arbutus Biopharma Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Arbutus Biopharma Key News & Latest Developments
Table 66. Lupin Pharmaceuticals Company Summary
Table 67. Lupin Pharmaceuticals Chronic Hepatitis B Treatment Product Offerings
Table 68. Lupin Pharmaceuticals Chronic Hepatitis B Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Lupin Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Chronic Hepatitis B Treatment Segment by Type in 2022
Figure 2. Chronic Hepatitis B Treatment Segment by Application in 2022
Figure 3. Global Chronic Hepatitis B Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chronic Hepatitis B Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chronic Hepatitis B Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Hepatitis B Treatment Revenue in 2022
Figure 8. By Type - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 16. US Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 28. China Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Chronic Hepatitis B Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Chronic Hepatitis B Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. ViiV Healthcare Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gilead Sciences Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Accord Healthcare Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Pharmaceuticals Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Apotex Corp Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. CTTQ Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Arbutus Biopharma Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lupin Pharmaceuticals Chronic Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
